About Us
Gems Biogenics International Ltd, Mauritius
Gems Biogenics is strategically entering the Mauritius pharmaceutical market with a clear mission: to provide highly potent and effective formulations with unique compositions at affordable prices. By targeting key segments such as neuro diabetes, cardiovascular health, antimicrobials, proton pump inhibitors, multivitamins, and antioxidants, the company aims to address critical healthcare needs.
The senior management team at Gems Biogenics brings a wealth of experience, boasting over 100 years of cumulative expertise from renowned organizations including Pfizer, Novartis, Aventis, Johnson Matthey, Ranbaxy, Alembic, Elder, Mankind, Aristo, and Alkem. This seasoned leadership is well-equipped to navigate the complexities of the pharmaceutical landscape, ensuring strategic alignment with market demands and regulatory standards.
Committed to accessibility, Gems Biogenics aspires to make a significant impact on healthcare affordability in the Indian Ocean region and East Africa. The company envisions substantial growth within the next three years, leveraging its expertise, innovative formulations, and deep understanding of the dynamic pharmaceutical sector to expand its footprint and contribute meaningfully to the well-being of the population across the region.
